Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas

被引:29
作者
Augstein, P
Bahr, J
Wachlin, G
Heinke, P
Berg, S
Salzsieder, E
Harrison, LC
机构
[1] Inst Diabet Gerhardt Katsch, D-17495 Karlsburg, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Dept Pathophysiol, D-17487 Greifswald, Germany
[3] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia
关键词
type I diabetes; beta-cell apoptosis; caspase-3; Fas expression; FasL; IL-1; beta; IFN-gamma; NIT-1; cells; NOD mouse islets; thymocytes;
D O I
10.1016/j.jaut.2004.09.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In type 1 diabetes, autoimmune inflammation of pancreatic islets of Langerhans ('insulitis') results in destruction of insulin-producing cells. Cytokines released from islet-infiltrating mononuclear cells are known to be cytotoxic both directly and by upregulating Fas for FasL-induced apoptosis. To investigate the role of caspase-3, a major effector of apoptosis in beta-cell death, we asked whether cytokine- and/or FasL-induced apoptosis was associated with increased activity of caspase-3 in NIT-1 insulinoma cells and islets of autoimmune diabetes-prone NOD mice. Measurement of caspase-3 activity using a fluorogenic cleavage assay was validated in NOD mouse thymocytes undergoing dexamethasone (Dex)-induced apoptosis. For cytokine-induced apoptosis, NIT- 1 cells or islets were exposed to IL-1beta and IFN-gamma for 24 h. Caspase-3-like activity was increased 2.1 +/- 0.7 and 2.4 +/- 0.9-fold in lysates of cytokine-treated NIT-1 cells and NOD mouse islets, respectively. However, NIT-1 cells exhibited 2.1% (4.7 pg active caspase-3/ mug protein) and islets 0.8% (1.9 pg active caspase-3/mug protein) of the active caspase-3 content observed in Dex-treated thymocytes (225.1 pg active caspase-3/mug protein). After 24 h cytokine-exposure, the percentage of Fas-positive NIT-1 cells increased from 1.4 +/- 1.1 to 29.7 +/- 11.6%. Addition of FasL for a further 3 h increased caspase-3-like activity an additional 1.8-fold in cytokine treated NIT-1 cells. In summary, exposure of NOD mouse insulinoma cells or islets to IL-1beta and IFN-gamma for 24 h induced caspase3-like activity that, in the case of insulinoma cells at least, can be further enhanced by interaction of cytokine-induced Fas receptor with FasL. Compared to thymocytes, insulinoma cells and islets from NOD mice were characterised by low basal and cytokine induced caspase-3 activity. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:301 / 309
页数:9
相关论文
共 40 条
  • [1] The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic β-cells
    Ammendrup, A
    Maillard, A
    Nielsen, K
    Andersen, NA
    Serup, P
    Madsen, OD
    Mandrup-Poulsen, T
    Bonny, C
    [J]. DIABETES, 2000, 49 (09) : 1468 - 1476
  • [2] Fas ligand down-regulates cytokine-induced fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice
    Augstein, P
    Heinke, P
    Salzsieder, E
    Berg, S
    Rettig, R
    Salzsieder, C
    Harrison, LC
    [J]. ENDOCRINOLOGY, 2004, 145 (06) : 2747 - 2752
  • [3] Surface and intracellular Fas expression associated with cytokine-induced apoptosis in rodent islet and insulinoma cells
    Augstein, P
    Wachlin, G
    Berg, S
    Bahr, J
    Salzsieder, C
    Hehmke, B
    Heinke, P
    Salzsieder, E
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2003, 30 (02) : 163 - 171
  • [4] Cell surface trafficking of Fas in NIT-1 cells and dissection of surface and total Fas expression
    Augstein, P
    Dunger, A
    Salzsieder, C
    Heinke, P
    Kubernath, R
    Bahr, J
    Fischer, U
    Rettig, R
    Salzsieder, E
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (01) : 443 - 451
  • [5] β-cell apoptosis in an accelerated model of autoimmune diabetes
    Augstein, P
    Stephens, LA
    Allison, J
    Elefanty, AG
    Ekberg, M
    Kay, TWH
    Harrison, LC
    [J]. MOLECULAR MEDICINE, 1998, 4 (08) : 495 - 501
  • [6] The CD95 type I/type II model
    Barnhart, BC
    Alappat, EC
    Peter, ME
    [J]. SEMINARS IN IMMUNOLOGY, 2003, 15 (03) : 185 - 193
  • [7] Caspase activation
    Boatright, KM
    Salvesen, GS
    [J]. PROTEASES AND THE REGULATION OF BIOLOGICAL PROCESSES, 2003, 70 : 233 - 242
  • [8] Inhibition of protein kinase C δ protects rat INS-1 cells against interleukin-1β and streptozotocin-induced apoptosis
    Carpenter, L
    Cordery, D
    Biden, TJ
    [J]. DIABETES, 2002, 51 (02) : 317 - 324
  • [9] Early assessment of apoptosis in isolated islets of langerhans
    Cattan, P
    Berney, T
    Schena, S
    Molano, RD
    Pileggi, A
    Vizzardelli, C
    Ricordi, C
    Inverardi, L
    [J]. TRANSPLANTATION, 2001, 71 (07) : 857 - 862
  • [10] Live and let die: regulatory mechanisms in Fas-mediated apoptosis
    Curtin, JF
    Cotter, TG
    [J]. CELLULAR SIGNALLING, 2003, 15 (11) : 983 - 992